ATA67688A - Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren - Google Patents

Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren

Info

Publication number
ATA67688A
ATA67688A AT0067688A AT67688A ATA67688A AT A67688 A ATA67688 A AT A67688A AT 0067688 A AT0067688 A AT 0067688A AT 67688 A AT67688 A AT 67688A AT A67688 A ATA67688 A AT A67688A
Authority
AT
Austria
Prior art keywords
haloalkyl
dithiine
oxathiine
leukaemia
tumors
Prior art date
Application number
AT0067688A
Other languages
English (en)
Other versions
AT397089B (de
Original Assignee
Uniroyal Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chemical Ltd filed Critical Uniroyal Chemical Ltd
Publication of ATA67688A publication Critical patent/ATA67688A/de
Application granted granted Critical
Publication of AT397089B publication Critical patent/AT397089B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT0067688A 1987-03-11 1988-03-11 Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukämie und tumoren AT397089B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2465787A 1987-03-11 1987-03-11
US07/146,512 US4822813A (en) 1987-03-11 1988-01-21 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith

Publications (2)

Publication Number Publication Date
ATA67688A true ATA67688A (de) 1993-06-15
AT397089B AT397089B (de) 1994-01-25

Family

ID=26698721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0067688A AT397089B (de) 1987-03-11 1988-03-11 Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukämie und tumoren

Country Status (20)

Country Link
US (1) US4822813A (de)
JP (1) JPS63264580A (de)
AT (1) AT397089B (de)
AU (1) AU597478B2 (de)
BE (1) BE1002181A3 (de)
CA (1) CA1320210C (de)
CH (1) CH674366A5 (de)
DE (1) DE3808024A1 (de)
DK (1) DK168707B1 (de)
ES (1) ES2011075A6 (de)
FR (1) FR2612188B1 (de)
GB (1) GB2201958B (de)
GR (1) GR1000238B (de)
IE (1) IE61955B1 (de)
IL (1) IL85517A (de)
IT (1) IT8819726A0 (de)
LU (1) LU87152A1 (de)
NL (1) NL8800531A (de)
NZ (1) NZ223798A (de)
SE (1) SE466400B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001327D0 (en) * 1990-01-19 1990-03-21 May & Baker Ltd New compositions of matter
HRP921128B1 (en) * 1991-10-30 1998-10-31 Sandor Garaczy Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof
CN106278845B (zh) * 2016-05-19 2019-03-05 海正化工南通有限公司 一种3,5-二氯-2-戊酮的合成工艺
CN106565441A (zh) * 2016-11-10 2017-04-19 安徽国星生物化学有限公司 一种3,5‑二氯‑2‑戊酮的合成方法
CN106673978B (zh) * 2016-11-30 2019-06-25 湖南化工研究院有限公司 3,5-二氯-2-戊酮的连续化合成方法
CN107473949B (zh) * 2017-09-26 2020-10-02 安徽国星生物化学有限公司 一种3,5-二氯-2-戊酮的合成工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868459A (en) * 1968-05-21 1975-02-25 Aquitaine Petrole Method of killing nematodes using certain halomethyl oxathienes
US3728357A (en) * 1970-09-08 1973-04-17 Uniroyal Inc 2-(substituted-methyl)-5,6-dihydro-1,4-oxathiin-3-carboxamides
US4319003A (en) * 1980-09-26 1982-03-09 General Motors Corporation Poly(methyl methacrylate) polycarbonate block copolymers

Also Published As

Publication number Publication date
DK131188A (da) 1988-09-12
DK168707B1 (da) 1994-05-24
GB2201958A (en) 1988-09-14
FR2612188A1 (fr) 1988-09-16
NZ223798A (en) 1989-12-21
JPS63264580A (ja) 1988-11-01
CA1320210C (en) 1993-07-13
AU1282788A (en) 1988-09-15
AT397089B (de) 1994-01-25
FR2612188B1 (fr) 1991-02-15
SE466400B (sv) 1992-02-10
AU597478B2 (en) 1990-05-31
ES2011075A6 (es) 1989-12-16
GB2201958B (en) 1990-10-10
BE1002181A3 (fr) 1990-10-02
CH674366A5 (de) 1990-05-31
DE3808024A1 (de) 1988-09-22
JPH0372221B2 (de) 1991-11-18
LU87152A1 (fr) 1988-11-17
SE8800863L (sv) 1989-09-12
US4822813A (en) 1989-04-18
IL85517A (en) 1992-09-06
GR1000238B (el) 1992-05-12
IL85517A0 (en) 1988-08-31
GR880100136A (en) 1989-01-31
IT8819726A0 (it) 1988-03-10
IE61955B1 (en) 1994-11-30
IE880597L (en) 1988-09-11
NL8800531A (nl) 1988-10-03
GB8804454D0 (en) 1988-03-23
SE8800863D0 (sv) 1988-03-10
DK131188D0 (da) 1988-03-10

Similar Documents

Publication Publication Date Title
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
NO167285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nafto(1,2-b)-1,4-tiazepinon-derivater.
ATA67688A (de) Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren
DE60126225D1 (de) Zusammensetzung zur Behandlung von Tumoren oder Krebs, welche Fluorouracil und ein Methylol Übertragungsmittel enthält
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
NO884698L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
ATE37871T1 (de) Substituierte azabicycloalkane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO166324C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer.
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO945094L (no) Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
NO890261L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELJ Ceased due to non-payment of the annual fee